PrEP clinic support study for Kenya health workers and policy makers
Part of Immune system & allergy, Infections clinical trials.
This trial tests a “one-stop” support pathway meant to make it easier for PrEP clinics in Kenya to deliver PrEP care. It involves interviews with people using PrEP services and with healthcare and policy leaders who help run or guide PrEP delivery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 15 years old
- You must be getting PrEP services at one of the participating clinics
- You must be someone who is eligible for PrEP based on Kenya’s national guidelines
- For interviews, you must be able and willing to give consent
- If you are a healthcare provider, you must work at a participating clinic
- If you are a policy maker, you must be part of the study’s policy-maker group
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new computer tool designed to help young adults and healthcare providers make better decisions about PrEP (a daily pill that prevents HIV). Researchers want to understand how this tool works in real clinics in Alabama and Botswana.
This study helps healthcare providers and clinics deliver long-acting injectable PrEP (a preventive HIV medication given as an injection) more effectively. Researchers will study how clinics can better implement and offer this option to patients who need it.
This study aims to expand access to PrEP (a daily pill that prevents HIV) for pregnant and postpartum women visiting maternal and child health clinics in Kenya. It also includes health care workers who provide PrEP services.
This study tests whether a program called 'PrEP My Way' can help young women in Kenya stick with taking PrEP pills to prevent HIV. It's designed for women ages 16–24 who are just starting PrEP in Kisumu County.
This trial tests a program where HIV testing counselors help family planning patients learn about and get PrEP, a daily pill that prevents HIV. It aims to make PrEP easier to access in clinics you may already visit.
This study is testing different ways to encourage people who are at higher risk for HIV to get retested regularly. If you are HIV-negative and get tested at a participating clinic, you may be eligible.
Hear when a new HIV Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.